One quarter into 2025, CVS Health has risen the most of any stock in the S&P 500, with a share price that has popped 50% since the start of the year.

CVS Health (CVS) is a top S&P 500 performer in 2025, with year-to-date returns exceeding 50%. Moreover, the stock has shirked off Trump-mania, tariff levies, and a global trade war like water off ...

CVS shares jumped Tuesday after the company improved its full-year outlook and named a new chief financial officer.

The first quarter is in the books, and the S&P 500’s best and worst performers are a pharmacy chain and a footwear company—certainly not the usual suspects.CVS Health was the N0. 1 stock with a gain ...

CVS Health surged 10% intraday and ended yesterday 6% higher. Check out why I think that CVS stock offers a significant ...

Truist Financial analyst David S Macdonald maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

The healthcare sector, as measured by Health Care Select Sector SPDR Fund (NYSEARCA:XLV), with 12.12% weightage on the S&P ...

Police say that the suspect walked into the CVS Pharmacy at 4055 Hylan Blvd. just before 5 p.m. The woman approached the cashier as if she were about to make a purchase, when suddenly, she ...

Year to date, the S&P 500 is now down nearly 4.5%, and many investors are worried that there could be further declines coming. The best-performing stock on this list is CVS Health, which has risen ...

One quarter into 2025, CVS Health (CVS) has gained the most of any stock in the S&P 500, with a share price that has popped 50% since the start of the year. Looking ahead, the analyst consensus ...

Truist Financial analyst David S Macdonald maintained a Buy rating on CVS Health (CVS – Research Report) today. The company’s shares closed ...